<DOC>
	<DOCNO>NCT01243957</DOCNO>
	<brief_summary>The purpose study measure difference body break inactivate either fluoxetine LY2216684 medicine give together . This study look fluoxetine might affect LY2216684 give LY2216684 might affect fluoxetine body . The duration study participation study approximately 36 day include screening appointment . This study require 1 research unit confinement 29 days/28 night follow 1 outpatient appointment . A screening appointment require within 30 day prior start study .</brief_summary>
	<brief_title>A Study Measure There Any Difference How Body Breaks Down Inactivates Either Fluoxetine LY2216684 When Both These Medicines Are Given Together .</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Phenylethyl Alcohol</mesh_term>
	<criteria>Are overtly healthy determine medical history physical examination . Male subject : Agree use reliable method birth control study 3 month follow last dose study drug . Female subject : Are woman childbearing potential test negative pregnancy time enrollment , use reliable method birth control 6 week prior administration study drug , agree use reliable method birth control study 1 month follow last dose study drug ; Women childbearing potential due surgical sterilization ( hysterectomy , bilateral oophorectomy , tubal ligation ) menopause ( least 1 year without menses 6 month without menses follicle stimulate hormone [ FSH ] level â‰¥40 mIU/mL ) . Are age 18 65 year , inclusive . Are body mass index 18.5 32.0 kg/m2 , inclusive . Have screen clinical laboratory test result within normal reference range population investigator site , result acceptable deviation judge clinically significant investigator . Have venous access sufficient allow blood sample per protocol . Have normal BP pulse rate ( supine position stand ) determine investigator . Are reliable willing make available duration study willing follow study procedure . Have give write informed consent approve Lilly institutional review board ( IRB ) govern site . Are investigator site personnel directly affiliate study immediate family . Immediate family define spouse , parent , child sibling , whether biological legally adopt . Are Lilly employee . Are currently enrol , discontinue within last 30 day , clinical trial involve investigational drug device study drug use study , concurrently enrol type medical research judge scientifically medically compatible study . Have know allergy LY2216684 , fluoxetine , related compound . Are person previously complete withdrawn study study investigate LY2216684 within 6 month prior screen . Have clinically significant abnormality 12lead ECG determine investigator . Have significant history current cardiovascular ( include dysrhythmias ) , respiratory , hepatic , renal , gastrointestinal , endocrine , hematological , neurological disorder capable significantly alter absorption , metabolism , elimination drug ; constitute risk take study medication ; interfere interpretation data . Have history seizure disorder . Have history presence sign and/or symptom hyponatremia . Have history presence sign and/or symptom hyperthyroidism determine abnormal thyroid stimulate hormone ( TSH ) screening . Show evidence significant active neuropsychiatric disease history suicidal thought attempt suicide . Regularly use know drug abuse and/or show positive finding urinary drug screening . Show evidence human immunodeficiency virus ( HIV ) and/or positive human HIV antibody . Show evidence hepatitis C and/or positive hepatitis C antibody . Show evidence hepatitis B and/or positive hepatitis B surface antigen . Are woman positive pregnancy test woman lactate . Intend use overthecounter prescription medication within 14 day prior dose unless deem acceptable investigator sponsor 's medical monitor Use drug substance know strong inducer inhibitor CYP2D6 within 30 day prior checkin Have donate blood 500 mL within 4 week prior screen . Have average weekly alcohol intake exceed 14 unit per week , unwilling stop alcohol consumption 48 hour prior Checkin completion study ( 1 unit = 12 oz 360 mL beer ; 5 oz 150 mL wine ; 1.5 oz 45 mL distilled spirit ) . Consume 5 cup coffee ( beverage comparable caffeine content ) per day , habitual basis , subject unwilling adhere study caffeine restriction . Have use tobaccocontaining nicotinecontaining product ( include limit cigarette , pipe , cigar , chew tobacco , nicotine patch , nicotine lozenge , nicotine gum ) within 6 month prior enrollment . Have consume grapefruit grapefruitcontaining product 7 day prior enrollment study . Have document suspected history glaucoma . Subjects determine unsuitable investigator reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>